Literature DB >> 17855521

DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication.

Yasuo Ariumi1, Misao Kuroki, Ken-ichi Abe, Hiromichi Dansako, Masanori Ikeda, Takaji Wakita, Nobuyuki Kato.   

Abstract

DDX3, a DEAD-box RNA helicase, binds to the hepatitis C virus (HCV) core protein. However, the role(s) of DDX3 in HCV replication is still not understood. Here we demonstrate that the accumulation of both genome-length HCV RNA (HCV-O, genotype 1b) and its replicon RNA were significantly suppressed in HuH-7-derived cells expressing short hairpin RNA targeted to DDX3 by lentivirus vector transduction. As well, RNA replication of JFH1 (genotype 2a) and release of the core into the culture supernatants were suppressed in DDX3 knockdown cells after inoculation of the cell culture-generated HCVcc. Thus, DDX3 is required for HCV RNA replication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855521      PMCID: PMC2168844          DOI: 10.1128/JVI.01517-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

Review 1.  DEAD-box proteins: the driving forces behind RNA metabolism.

Authors:  Sanda Rocak; Patrick Linder
Journal:  Nat Rev Mol Cell Biol       Date:  2004-03       Impact factor: 94.444

2.  Induction of an interferon response by RNAi vectors in mammalian cells.

Authors:  Alan J Bridge; Stephanie Pebernard; Annick Ducraux; Anne-Laure Nicoulaz; Richard Iggo
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

3.  Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.

Authors:  R Zufferey; D Nagy; R J Mandel; L Naldini; D Trono
Journal:  Nat Biotechnol       Date:  1997-09       Impact factor: 54.908

4.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

5.  Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function.

Authors:  Venkat S R K Yedavalli; Christine Neuveut; Ya-Hui Chi; Lawrence Kleiman; Kuan-Teh Jeang
Journal:  Cell       Date:  2004-10-29       Impact factor: 41.582

6.  Hepatitis C virus core protein interacts with a human DEAD box protein DDX3.

Authors:  A M Owsianka; A H Patel
Journal:  Virology       Date:  1999-05-10       Impact factor: 3.616

7.  Hepatitis C virus core protein interacts with cellular putative RNA helicase.

Authors:  L R You; C M Chen; T S Yeh; T Y Tsai; R T Mai; C H Lin; Y H Lee
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  Distinct nuclear body components, PML and SMRT, regulate the trans-acting function of HTLV-1 Tax oncoprotein.

Authors:  Yasuo Ariumi; Takeshi Ego; Atsushi Kaida; Mikiko Matsumoto; Pier Paolo Pandolfi; Kunitada Shimotohno
Journal:  Oncogene       Date:  2003-03-20       Impact factor: 9.867

9.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

10.  Cellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replication.

Authors:  Phuay-Yee Goh; Yee-Joo Tan; Siew Pheng Lim; Y H Tan; Seng Gee Lim; Frances Fuller-Pace; Wanjin Hong
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more
  126 in total

1.  DDX3 regulates cell growth through translational control of cyclin E1.

Authors:  Ming-Chih Lai; Wen-Cheng Chang; Sheau-Yann Shieh; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2010-09-13       Impact factor: 4.272

Review 2.  RNA helicases: emerging roles in viral replication and the host innate response.

Authors:  Arnaz Ranji; Kathleen Boris-Lawrie
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

3.  DHX9 pairs with IPS-1 to sense double-stranded RNA in myeloid dendritic cells.

Authors:  Zhiqiang Zhang; Bin Yuan; Ning Lu; Valeria Facchinetti; Yong-Jun Liu
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

4.  DDX3 Interacts with Influenza A Virus NS1 and NP Proteins and Exerts Antiviral Function through Regulation of Stress Granule Formation.

Authors:  Sathya N Thulasi Raman; Guanqun Liu; Hyun Mi Pyo; Ya Cheng Cui; Fang Xu; Lisanework E Ayalew; Suresh K Tikoo; Yan Zhou
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

5.  Proteomic analysis of human hepatoma cells expressing methionine adenosyltransferase I/III: Characterization of DDX3X as a target of S-adenosylmethionine.

Authors:  Paul C Schröder; Joaquín Fernández-Irigoyen; Emilie Bigaud; Antonio Serna; Rubén Renández-Alcoceba; Shelly C Lu; José M Mato; Jesús Prieto; Fernando J Corrales
Journal:  J Proteomics       Date:  2012-01-16       Impact factor: 4.044

6.  The ATP-Dependent RNA Helicase DDX3X Modulates Herpes Simplex Virus 1 Gene Expression.

Authors:  Bita Khadivjam; Camille Stegen; Marc-Aurèle Hogue-Racine; Nabil El Bilali; Katinka Döhner; Beate Sodeik; Roger Lippé
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

7.  How the antiviral immune response boosts liver fat.

Authors:  Gregory Camus; Melanie Ott
Journal:  Nat Med       Date:  2013-06       Impact factor: 53.440

8.  Cytoplasmic dsRNA induces the expression of OCT3/4 and NANOG mRNAs in differentiated human cells.

Authors:  Guanming Wang; Takahisa Kouwaki; Kazuki Mugikura; Masaaki Okamoto; Hiromi Takaki; Kenji Funami; Tsukasa Seya; Hiroyuki Oshiumi
Journal:  J Biol Chem       Date:  2019-10-15       Impact factor: 5.157

9.  DDX3 DEAD-Box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids.

Authors:  Haifeng Wang; Seahee Kim; Wang-Shick Ryu
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  Cytoplasmic RNA Granules and Viral Infection.

Authors:  Wei-Chih Tsai; Richard E Lloyd
Journal:  Annu Rev Virol       Date:  2014-11       Impact factor: 10.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.